Cargando…
Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome
One of the most serious problems in people with diabetes is diabetic foot syndrome. Due to the peripheral location of atherosclerotic lesions in the arterial system of the lower extremities, endovascular treatment plays a dominant role. However, carrying out these procedures is not always possible a...
Autores principales: | Barć, Piotr, Antkiewicz, Maciej, Frączkowska-Sioma, Katarzyna, Kupczyńska, Diana, Lubieniecki, Paweł, Witkiewicz, Wojciech, Małodobra-Mazur, Małgorzata, Baczyńska, Dagmara, Janczak, Dariusz, Skóra, Jan Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564889/ https://www.ncbi.nlm.nih.gov/pubmed/36232122 http://dx.doi.org/10.3390/ijerph191912818 |
Ejemplares similares
-
Complementary Gene Therapy after Revascularization with the Saphenous Vein in Diabetic Foot Syndrome
por: Kupczyńska, Diana, et al.
Publicado: (2023) -
Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus
por: Barć, Piotr, et al.
Publicado: (2020) -
Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
por: Skóra, Jan, et al.
Publicado: (2014) -
Therapeutic Angiogenesis Using HGF Plasmid
por: Sanada, Fumihiro, et al.
Publicado: (2020) -
Presence of Periodontopathic Bacteria DNA in Atheromatous Plaques from Coronary and Carotid Arteries
por: Szulc, Malgorzata, et al.
Publicado: (2015)